Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-03 Sale |
2025-03-03 5:29 pm |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
5,825 | $14.49 | $84,388 | 33,724 (Direct) |
View |
| 2025-01-30 Sale |
2025-01-30 7:43 pm |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
2,811 | $19.85 | $55,809 | 94,844 (Direct) |
View |
| 2024-11-01 Sale |
2024-11-01 5:57 pm |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
3,546 | $24.28 | $86,083 | 33,724 (Direct) |
View |
| 2024-10-30 Sale |
2024-10-30 8:30 pm |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
2,368 | $24.3 | $57,554 | 101,201 (Direct) |
View |
| 2024-08-26 Sale |
2024-08-26 5:41 pm |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
20,000 | $25.22 | $504,370 | 31,002 (Direct) |
View |
| 2024-08-01 Sale |
2024-08-01 7:06 pm |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
3,477 | $21.45 | $74,576 | 51,002 (Direct) |
View |
| 2024-07-30 Sale |
2024-07-30 7:06 pm |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
2,490 | $20.67 | $51,463 | 127,046 (Direct) |
View |
| 2024-06-20 Sale |
2024-06-20 4:58 pm |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
20,000 | $20.01 | $400,216 | 48,333 (Direct) |
View |
| 2024-05-02 Sale |
2024-05-02 6:01 pm |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
3,499 | $12.83 | $44,878 | 68,333 (Direct) |
View |
| 2024-04-30 Sale |
2024-04-30 6:33 pm |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
1,387 | $12.04 | $16,703 | 108,035 (Direct) |
View |
| 2024-02-16 Sale |
2024-02-16 7:20 pm |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
6,812 | $10.02 | $68,223 | 68,333 (Direct) |
View |
| 2024-01-30 Sale |
2024-01-30 6:53 pm |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
1,671 | $7.9902 | $13,352 | 116,234 (Direct) |
View |
| 2023-12-20 Sale |
2023-12-21 5:19 pm |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
3,541 | $10 | $35,421 | 71,930 (Direct) |
View |
| 2023-12-19 Sale |
2023-12-20 4:55 pm |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
10,906 | $10 | $109,093 | 75,471 (Direct) |
View |
| 2023-10-31 Sale |
2023-11-01 4:41 pm |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
1,080 | $5.1974 | $5,613 | 132,352 (Direct) |
View |
| 2023-07-31 Sale |
2023-08-01 4:28 pm |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
1,245 | $9.6547 | $12,020 | 133,432 (Direct) |
View |
| 2023-05-01 Sale |
2023-05-02 4:33 pm |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
721 | $9.8763 | $7,121 | 110,677 (Direct) |
View |
| 2023-01-30 Sale |
2023-02-01 4:17 pm |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
924 | $11.78 | $10,884 | 111,398 (Direct) |
View |
| 2022-10-31 Sale |
2022-11-01 7:35 pm |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
739 | $12.88 | $9,519 | 112,322 (Direct) |
View |
| 2022-08-01 Sale |
2022-08-02 5:46 pm |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
752 | $15.67 | $11,784 | 113,061 (Direct) |
View |
| 2022-05-02 Sale |
2022-05-03 7:03 pm |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
697 | $11.75 | $8,190 | 45,480 (Direct) |
View |
| 2021-02-24 Sale |
2021-02-25 4:18 pm |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
35,419 | $39.9 | $1,413,218 | 65,667 (Direct) |
View |
| 2021-02-22 Sale |
2021-02-23 6:04 pm |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
5,330 | $39.93 | $212,839 | 97,753 (Direct) |
View |
| 2021-02-18 Sale |
2021-02-22 4:09 pm |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
13,583 | $35.46 | $481,621 | 69,750 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-11 Option Award |
2025-02-13 4:12 pm |
N/A 2035-02-10 |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
109,300 | $0 | 109,300 (Direct) |
View |
| 2025-01-30 Exercise |
2025-01-30 7:43 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
8,636 | $0 | 94,844 (Direct) |
View |
| 2024-10-30 Exercise |
2024-10-30 8:30 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
8,636 | $0 | 101,201 (Direct) |
View |
| 2024-07-30 Exercise |
2024-07-30 7:06 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
8,636 | $0 | 127,046 (Direct) |
View |
| 2024-04-30 Exercise |
2024-04-30 6:33 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
4,886 | $0 | 108,035 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-15 07:23 am |
N/A 2034-02-12 |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
195,000 | $0 | 195,000 (Direct) |
View |
| 2024-01-30 Exercise |
2024-01-30 6:53 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
4,886 | $0 | 116,234 (Direct) |
View |
| 2023-10-30 Exercise |
2023-11-01 4:41 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
4,886 | $0 | 132,352 (Direct) |
View |
| 2023-07-30 Exercise |
2023-08-01 4:28 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
4,886 | $0 | 133,432 (Direct) |
View |
| 2023-04-30 Exercise |
2023-05-02 4:33 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
2,886 | $0 | 110,677 (Direct) |
View |
| 2023-02-14 Option Award |
2023-02-15 4:13 pm |
N/A 2033-02-13 |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
112,900 | $0 | 112,900 (Direct) |
View |
| 2023-01-30 Exercise |
2023-02-01 4:17 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
2,886 | $0 | 111,398 (Direct) |
View |
| 2022-10-30 Exercise |
2022-11-01 7:35 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
2,886 | $0 | 112,322 (Direct) |
View |
| 2022-08-09 Option Award |
2022-08-10 4:17 pm |
N/A 2032-08-08 |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
120,000 | $0 | 120,000 (Direct) |
View |
| 2022-07-30 Exercise |
2022-08-02 5:46 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
2,886 | $0 | 113,061 (Direct) |
View |
| 2022-05-31 Exercise |
2022-06-01 4:57 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
68,333 | $0.84 | 70,522 (Direct) |
View |
| 2022-05-31 Exercise |
2022-06-01 4:57 pm |
N/A 2026-04-26 |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
68,333 | $0 | 70,522 (Direct) |
View |
| 2022-04-30 Exercise |
2022-05-03 7:03 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
2,886 | $0 | 45,480 (Direct) |
View |
| 2022-01-19 Option Award |
2022-01-21 4:16 pm |
N/A 2032-01-18 |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
150,071 | $0 | 150,071 (Direct) |
View |
| 2021-02-24 Exercise |
2021-02-25 4:18 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
20,393 | $1.2 | 65,667 (Direct) |
View |
| 2021-02-24 Exercise |
2021-02-25 4:18 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
13,197 | $1.86 | 65,667 (Direct) |
View |
| 2021-02-24 Exercise |
2021-02-25 4:18 pm |
N/A 2028-03-01 |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
35,419 | $0 | 65,667 (Direct) |
View |
| 2021-02-24 Exercise |
2021-02-25 4:18 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
1,829 | $7.26 | 65,667 (Direct) |
View |
| 2021-02-22 Exercise |
2021-02-23 6:04 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
1,417 | $0.84 | 97,753 (Direct) |
View |
| 2021-02-22 Exercise |
2021-02-23 6:04 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
3,913 | $1.2 | 97,753 (Direct) |
View |
| 2021-02-22 Exercise |
2021-02-23 6:04 pm |
N/A 2026-04-26 |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
5,330 | $0 | 97,753 (Direct) |
View |
| 2021-02-18 Exercise |
2021-02-22 4:09 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
13,583 | $0.84 | 69,750 (Direct) |
View |
| 2021-02-18 Exercise |
2021-02-22 4:09 pm |
N/A 2026-01-27 |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
13,583 | $0 | 69,750 (Direct) |
View |
| 2021-02-11 Option Award |
2021-02-12 7:27 pm |
N/A 2031-02-10 |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
40,000 | $0 | 40,000 (Direct) |
View |
Ownership |
2020-07-23 6:46 pm |
N/A 2028-03-01 |
Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer |
0 | $0 | 271,665 (Direct) |
View |